A recent study published in JAMA, the CIRCUIT trial, has shown that a closed-loop insulin delivery system can significantly improve glucose control in pregnant women with type 1 diabetes.
The trial found that women using the closed-loop system spent more time within the target glucose range, with less time above or below targets, and had lower average glucose and HbA1c levels compared to those receiving standard care.
The study demonstrates the potential benefits of closed-loop insulin delivery in managing type 1 diabetes during pregnancy.
The study's findings were reported by Dr. Kamal Kant Kohli, a chest specialist and Chief Editor of Medical News at Medical Dialogues.
Author's summary: Closed-loop insulin delivery improves glucose control in pregnant women with type 1 diabetes.